Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

BUY
$10.27 - $13.29 $277 - $358
27 Added 0.08%
33,277 $0
Q2 2022

Jul 26, 2022

BUY
$7.45 - $12.83 $61,462 - $105,847
8,250 Added 33.0%
33,250 $419,000
Q4 2021

Jan 18, 2022

BUY
$13.17 - $20.94 $171,210 - $272,220
13,000 Added 108.33%
25,000 $352,000
Q3 2021

Oct 07, 2021

BUY
$9.16 - $19.83 $109,920 - $237,959
12,000 New
12,000 $231,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.74B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Caprock Group, Inc. Portfolio

Follow Caprock Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.